Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Génétique des Maladies du Développement, |
RCV001004671 | SCV001164122 | uncertain significance | Alternating hemiplegia of childhood 2 | 2016-08-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001585916 | SCV001820042 | likely pathogenic | not provided | 2024-10-25 | criteria provided, single submitter | clinical testing | Reported previously in an individual with child-onset schizophrenia, autism spectrum disorder, and intellectual disability; inherited form an unaffected mother (PMID: 29895895); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 33046383, 29895895, 35978945) |
Centre de Biologie Pathologie Génétique, |
RCV002274115 | SCV002558927 | likely pathogenic | Neurodevelopmental delay | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV003626655 | SCV004422663 | uncertain significance | Dystonia 12 | 2023-01-20 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ATP1A3 protein function. ClinVar contains an entry for this variant (Variation ID: 813739). This variant has not been reported in the literature in individuals affected with ATP1A3-related conditions. This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 813 of the ATP1A3 protein (p.Ala813Val). |